Coxiella burnetii-specific CD4+ T cell

Coxiella burnetii-specific CD4+ T cells are a specialized population of helper T lymphocytes that play a critical role in the adaptive immune response against the intracellular bacterium Coxiella burnetii, the causative agent of Q fever (Scholzen et al., 2019, Journal of Immunology). These cells recognize specific bacterial peptide fragments, known as epitopes, which are processed and presented on the surface of antigen-presenting cells by Human Leukocyte Antigen (HLA) class II molecules (Long et al., 2019, Frontiers in Immunology). Upon recognition of these HLA-peptide complexes via their T-cell receptors (TCRs), the CD4+ T cells become activated and secrete pro-inflammatory cytokines, most notably interferon-gamma (IFN-gamma). This cytokine signaling is essential for activating macrophages to restrict the intracellular replication of C. burnetii (CDC, 2021). In the context of drug and vaccine development, these T cells and their corresponding HLA-presented epitopes are primary targets for the design of next-generation subunit vaccines aimed at providing protective immunity without the adverse reactogenicity associated with traditional whole-cell vaccines like Q-Vax.

Other names

C. burnetii-reactive CD4+ T cellsQ fever-specific T cellsAntigen-specific CD4+ T lymphocytes

Activation of CD4+ T cells through T-cell receptor (TCR) recognition of Coxiella burnetii-derived peptide epitopes presented on HLA class II molecules, leading to the production of interferon-gamma (IFN-gamma) and subsequent macrophage activation for bacterial clearance.